Hemophagocytic lymphohistiocytosis in Egyptian children: diagnosis, treatment challenges, and outcome

Authors:

Abstract
Hemophagocyticlymphohistiocytosis (HLH) is a spectrum of immune activation which could be genetically determined, or secondaryto an underlying illness. Our aim was to present the clinico-genetic aspects ofHLH among Egyptian children and to evaluate the patterns of reactivation and outcomewith illustrations of overlap manifestations. We retrospectively collected the data of 55patients with HLH, registered at Ain Shams University Children's Hospital,Cairo, Egypt. Median age at diagnosis was 19 months (range 2-180), 33 patients (60%)fulfilled the diagnostic HLH criteria at presentation. Fourteen (25.45%) patients had secondary HLH, 15 (27.27%) patients had geneticallydocumented familial HLH (11 had variants in UNC13D gene and one in PRF1 gene), 3 had Griscelli and Chediak-Higashi syndrome. Sixteen patients (29.1%) had reactivations, 8(50%) of themhad molecularly confirmed HLH. Wereport the death of 40 patients, the median duration from the diagnosis todeath of 5 months mostly due to disease activity. This study confirms that the nonspecific signsand symptoms of HLH arechallenging. Genetic testing, though expensive and sophisticated, is integralfor the diagnosis. The difficulty in finding non-related donors for stem celltransplantation and the early reactivations are the causes of the inferioroutcome.
Funding Information
  • Institut National de la Santé et de la Recherche Médicale
  • Lymphohistiocytose Famililale Espoir

This publication has 44 references indexed in Scilit: